{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:23:23Z","timestamp":1793813003126,"version":"4.6.1"},"reference-count":36,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2024,3,9]]},"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n<jats:title>Introduction<\/jats:title>\n<jats:p>The government-funded pre-exposure prophylaxis (PrEP) programme was targeted to those aged under 30 years or serodiscordant couples and implemented in September 2018\u2013October 2020 in Taiwan. The study aimed to examine the effectiveness of the programme and the relationship between sexually transmitted disease (STD) and HIV seroconversion.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This study was a retrospective cohort analysis with questionnaires designed for participants who joined the aforementioned programme in the PrEP-designated hospitals. The questionnaires included sociodemographic factors, sexual risk behaviours, number and types of sexual partners, and usage of narcotics filled in at the beginning of the programme and every 3\u2009months. The McNemar test was used for the paired questionnaire analysis. The HIV seroconversion status among STD-notified patients nationwide was confirmed by using the data linkage method, followed up until October 2021 with stratification of PrEP programme participation or not.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n    <jats:p>The programme recruited 2155 people. 11 participants (0.5%) had seroconversion within the programme, while 26 (1.2%) had seroconversion after withdrawing from the programme. Overall, 1892 subjects with repeated questionnaires were included in the analysis for behaviour changes with median follow-up of 289 days. After joining the programme, 94.7% of them claimed that they had sexual behaviours: the rate of those who had condomless sex rose to 5.5% (p&lt;0.001) and the rate of those who used narcotics decreased to 2% (p&lt;0.001), compared with their response in the pre-questionnaire. Notably, the frequency of non-use of narcotics in recent 3\u2009months increased from 16.9% to 38.4% in the pre-questionnaire and post-questionnaire responses, among the 177 who had claimed narcotics usage in recent 12 months (p=0.003). More HIV seroconversion was found among patients with STD who did not join the programme than those who joined the programme (8.7% vs 4.9%, p=0.031).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The government-funded programme showed HIV case reduction and positive changes in health behaviours except for condomless sex which had increased prevalence. The reduction of HIV cases was also observed among people with STD. More resources should be allocated to the PrEP programme.<\/jats:p>\n<\/jats:sec>","DOI":"10.1136\/sextrans-2023-055917","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T01:17:23Z","timestamp":1717377443000},"page":"216-221","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["In the fight against HIV\/AIDS: the arduous implementation of government-funded pre-exposure prophylaxis programme in Taiwan"],"prefix":"10.1136","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0730-8935","authenticated-orcid":false,"given":"Hsun Yin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyun Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7424-1868","authenticated-orcid":false,"given":"Pei Chun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia Chi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"key":"2024062021351733000_100.4.216.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011205"},{"key":"2024062021351733000_100.4.216.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00056-2"},{"key":"2024062021351733000_100.4.216.3","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2016.1146653"},{"key":"2024062021351733000_100.4.216.4","unstructured":"Coalition AVA . Country overview:South Korea. 2023. Available: https:\/\/www.prepwatch.org\/countries\/south-korea\/ [Accessed 19 Oct 2023]."},{"key":"2024062021351733000_100.4.216.5","unstructured":"Coalition AVA . Country overview:Japan. 2023. Available: https:\/\/www.prepwatch.org\/countries\/japan\/ [Accessed 19 Oct 2023]."},{"key":"2024062021351733000_100.4.216.6","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1080\/22221751.2022.2081620","article-title":"Hepatitis C microelimination among people living with HIV in Taiwan","volume":"11","author":"Chen","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"2024062021351733000_100.4.216.7","unstructured":"Taiwan Centers for Diseases Control . HIV monthly report. 2022."},{"key":"2024062021351733000_100.4.216.8","unstructured":"Staff writer wC . Government to subsidize HIV prophylactic regime. Taiwan News. 2016."},{"key":"2024062021351733000_100.4.216.9","unstructured":"A new strategy for the prevention and treatment of HIV infection. The CDC launched a pre-exposure prophylaxis plan. high-risk can receive medication and reduce the risk of infection. 2016."},{"key":"2024062021351733000_100.4.216.10","unstructured":"Chen W-T . Anti-drug groups question prep drug resistance, CDC clarifies. 2017."},{"key":"2024062021351733000_100.4.216.11","unstructured":"Gerber A . Group opposing gay marriage to focus on drugs. Taiwan News. 2017."},{"key":"2024062021351733000_100.4.216.12","unstructured":"Prep dating pills will be included in health insurance. Netizens criticize: the whole people refuse to pay! 2017."},{"key":"2024062021351733000_100.4.216.13","unstructured":"Act for implementation of J.Y. interpretation no. 748. 2019."},{"key":"2024062021351733000_100.4.216.14","unstructured":"Sainty L , Kassy C . BuzzFeed news. 2017. Available: https:\/\/www.buzzfeednews.com\/article\/lanesainty\/taiwanese-court-delivers-landmark-marriage-ruling"},{"key":"2024062021351733000_100.4.216.15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1057\/s41292-022-00273-9","article-title":"Sexual health as surplus: the marketization of PrEP in Taiwan","volume":"18","author":"Huang","year":"2023","journal-title":"BioSocieties"},{"key":"2024062021351733000_100.4.216.16","unstructured":"I-chia L . Program aims to prevent HIV in high-risk groups. Taiwan News. 2018."},{"key":"2024062021351733000_100.4.216.17","unstructured":"Taiwan Centers for Diseases Control . Definition of communicable diseases. 2022. Available: https:\/\/www.cdc.gov.tw\/Category\/DiseaseDefine\/ZW54U0FpVVhpVGR3UkViWm8rQkNwUT09"},{"key":"2024062021351733000_100.4.216.18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.48782","article-title":"Association of HIV preexposure prophylaxis use with HIV incidence among men who have sex with men in China: a nonrandomized controlled trial","volume":"5","author":"Wang","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2024062021351733000_100.4.216.19","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25472","article-title":"Missed opportunities to prevent HIV infections among pre\u2010exposure prophylaxis users: a population\u2010based mixed methods study, San Francisco, United States","volume":"23","author":"Spinelli","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"2024062021351733000_100.4.216.20","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/OLQ.0b013e3181812939","article-title":"Changes in sexual risk behavior among participants in a PrEP HIV prevention trial","volume":"35","author":"Guest","year":"2008","journal-title":"Sex Transm Dis"},{"key":"2024062021351733000_100.4.216.21","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-018-2252-9"},{"key":"2024062021351733000_100.4.216.22","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2019-054345"},{"key":"2024062021351733000_100.4.216.23","doi-asserted-by":"crossref","first-page":"108875","DOI":"10.1016\/j.drugalcdep.2021.108875","article-title":"Chemsex practices and pre-exposure prophylaxis (PrEP) trajectories among individuals consulting for PrEP at a large sexual health clinic in Montr\u00e9al, Canada (2013-2020)","volume":"226","author":"Flores Anato","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"2024062021351733000_100.4.216.24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216732","article-title":"Chemsex among men who have sex with men living outside major cities and associations with sexually transmitted infections: a cross-sectional study in the Netherlands","volume":"14","author":"Evers","year":"2019","journal-title":"PLoS One"},{"key":"2024062021351733000_100.4.216.25","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/add.15666","article-title":"Increase in recreational drug use between 2008 and 2018: results from a prospective cohort study among HIV\u2010negative men who have sex with men","volume":"117","author":"Coyer","year":"2022","journal-title":"Addiction"},{"key":"2024062021351733000_100.4.216.26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/hiv.12821","article-title":"Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV cohort study from 2007 to 2017","volume":"21","author":"Hampel","year":"2020","journal-title":"HIV Med"},{"key":"2024062021351733000_100.4.216.27","doi-asserted-by":"crossref","first-page":"109741","DOI":"10.1016\/j.drugalcdep.2022.109741","article-title":"Chemsex and chemsex associated substance use among men who have sex with men in Asia: a systematic review and meta-analysis","volume":"243","author":"Wang","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"2024062021351733000_100.4.216.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.11.014"},{"key":"2024062021351733000_100.4.216.29","first-page":"11","article-title":"Risk compensation in PrEP: an old debate emerges yet again","volume":"16","author":"Blumenthal","year":"2014","journal-title":"Virtual Mentor"},{"key":"2024062021351733000_100.4.216.30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drugpo.2019.03.021","article-title":"Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: findings from the AURAH2 study","volume":"68","author":"Sewell","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2024062021351733000_100.4.216.31","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/00224499.2021.2012638","article-title":"Pleasure and PrEP: a systematic review of studies examining pleasure, sexual satisfaction, and PrEP","volume":"59","author":"Curley","year":"2022","journal-title":"J Sex Res"},{"key":"2024062021351733000_100.4.216.32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/19359705.2019.1688216","article-title":"Use of PrEP, sexual behaviors and mental health correlates in a sample of gay, bisexual and other men who have sex with men","volume":"24","author":"Moeller","year":"2020","journal-title":"J Gay Lesbian Mental Health"},{"key":"2024062021351733000_100.4.216.33","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31828f097a"},{"key":"2024062021351733000_100.4.216.34","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/01.aids.0000255084.69846.97","article-title":"Unprotected sex in regular partnerships among homosexual men living with HIV: a comparison between sero-nonconcordant and seroconcordant couples (ANRS-EN12-VESPA Study)","volume":"21","author":"Bouhnik","year":"2007","journal-title":"AIDS"},{"key":"2024062021351733000_100.4.216.35","doi-asserted-by":"publisher","DOI":"10.1080\/09540120500358951"},{"key":"2024062021351733000_100.4.216.36","doi-asserted-by":"crossref","unstructured":"Eisen EA , Picciotto S , Robins JM . Healthy worker effect. Encycl Environmetrics 2006. doi:10.1002\/0470011815","DOI":"10.1002\/0470011815.b2a03071"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2023-055917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T19:31:44Z","timestamp":1719257504000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2023-055917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,4]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,5,31]]},"published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1136\/sextrans-2023-055917"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2023-055917","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,4]]}}}